MedPath

Methylfenidaat afbouw studie bij kindere

Conditions
ADHD
attention deficit/hyperactivity disorder
methylphenidate
long-term effectiveness
methylfenidaat
lange termijn effectiviteit
aandachtstekortstoornis met hyperactiviteit
Registration Number
NL-OMON27718
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

•Children between the ages of eight to eighteen, any ethnicity or cultural background.

Exclusion Criteria

Excluded from participation in this study will be:

•Children who have not been using of methylphenidate for a continuous period > 2 months during the last two years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADHD-DSM-5 RS
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath